胰岛增强剂维格列汀：与二甲双胍联合治疗2型糖尿病患者的有力搭档。 - Suppr

Suppr

超能文献

Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.

作者信息

Scherbaum W A

机构信息

Department of Endocrinology, Diabetes & Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany.

出版信息

Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.

DOI:10.1111/j.1463-1326.2008.01032.x

PMID:19385977

Abstract

摘要

相似文献

Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.

Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.

Vildagliptin and vildagliptin/metformin: new drug. Same limited efficacy as sitagliptin in type 2 diabetes.

Prescrire Int. 2008 Oct;17(97):188.

The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond.

Diabetes Obes Metab. 2007 Sep;9 Suppl 1:32-9. doi: 10.1111/j.1463-1326.2007.00763.x.

Three new drugs for type 2 diabetes.

Drug Ther Bull. 2008 Jul;46(7):49-52. doi: 10.1136/dtb.2008.06.0014.

Vildagliptin monotherapy. To be avoided, like other DPP-4 inhibitors.

Prescrire Int. 2013 May;22(138):121.

Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.

Horm Metab Res. 2007 Nov;39(11):826-9. doi: 10.1055/s-2007-991172.

Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.

Int J Clin Pract Suppl. 2007 Aug(154):38-48. doi: 10.1111/j.1742-1241.2007.01439.x.

Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

Diabetes Care. 2007 Apr;30(4):890-5. doi: 10.2337/dc06-1732. Epub 2007 Feb 2.

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.

Diabetes Metab. 2012 Oct;38(4):359-66. doi: 10.1016/j.diabet.2012.06.001. Epub 2012 Jul 17.

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.

Expert Opin Pharmacother. 2012 Jun;13(9):1377-84. doi: 10.1517/14656566.2012.667078. Epub 2012 Mar 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.

作者信息

Scherbaum W A

机构信息

Department of Endocrinology, Diabetes & Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany.

出版信息

Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.

DOI:10.1111/j.1463-1326.2008.01032.x

PMID:19385977

Abstract

摘要

相似文献

Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.

Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.

Vildagliptin and vildagliptin/metformin: new drug. Same limited efficacy as sitagliptin in type 2 diabetes.

Prescrire Int. 2008 Oct;17(97):188.

The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond.

Diabetes Obes Metab. 2007 Sep;9 Suppl 1:32-9. doi: 10.1111/j.1463-1326.2007.00763.x.

Three new drugs for type 2 diabetes.

Drug Ther Bull. 2008 Jul;46(7):49-52. doi: 10.1136/dtb.2008.06.0014.

Vildagliptin monotherapy. To be avoided, like other DPP-4 inhibitors.

Prescrire Int. 2013 May;22(138):121.

Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.

Horm Metab Res. 2007 Nov;39(11):826-9. doi: 10.1055/s-2007-991172.

Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.

Int J Clin Pract Suppl. 2007 Aug(154):38-48. doi: 10.1111/j.1742-1241.2007.01439.x.

Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

Diabetes Care. 2007 Apr;30(4):890-5. doi: 10.2337/dc06-1732. Epub 2007 Feb 2.

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.

Diabetes Metab. 2012 Oct;38(4):359-66. doi: 10.1016/j.diabet.2012.06.001. Epub 2012 Jul 17.

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.

Expert Opin Pharmacother. 2012 Jun;13(9):1377-84. doi: 10.1517/14656566.2012.667078. Epub 2012 Mar 7.